Search research articles
Contact Us
Filters
Showing results (151-160 of 167) with videos related to
Page
of 17
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
May 8, 2007
Inhibitors of hepatitis C virus NS3.4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics
Robert B Perni, Gurudatt Chandorkar, Kevin M Cottrell, et al.
BJU International
|
October 7, 2021
Management of chronic primary pelvic pain syndromes
Brian A Parsons, Andrew P Baranowski, Bary Berghmans, et al.
Translational Oncology
|
January 5, 2025
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
Kimberly J Briggs, Kevin M Cottrell, Matthew R Tonini, et al.
The Journal of Biological Chemistry
|
February 10, 2004
In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms
Chao Lin, Kai Lin, Yu-Ping Luong, et al.
European Urology Open Science
|
September 15, 2023
The Benefits and Harms of Pharmacological Treatment for Postradiation Pelvic Pain: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel with Recommendations for Clinical Practice
Valentin Zumstein, Brian A Parsons, Saeed Dabestani, et al.
European Urology Focus
|
August 9, 2022
Myofascial Pelvic Pain: Best Orientation and Clinical Practice. Position of the European Association of Urology Guidelines Panel on Chronic Pelvic Pain
Pedro Abreu-Mendes, Andrew P Baranowski, Bary Berghmans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2025
MTA-Cooperative PRMT5 Inhibitors are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
Xiaochun Zhang, Dana C Borcherding, Minjie Zhang, et al.
European Urology Focus
|
February 2, 2021
The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel
Brian A Parsons, Sanchia Goonewardene, Saeed Dabestani, et al.
Journal of Medicinal Chemistry
|
April 10, 2024
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted Cancers
Kevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, et al.
Journal of Medicinal Chemistry
|
June 30, 2015
Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γ
Philip N Collier, David Messersmith, Arnaud Le Tiran, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 167) with videos related to
Sort By:
Page
of 17
Bioorganic & Medicinal Chemistry Letters
|
May 8, 2007
Inhibitors of hepatitis C virus NS3.4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics
Robert B Perni, Gurudatt Chandorkar, Kevin M Cottrell, et al.
BJU International
|
October 7, 2021
Management of chronic primary pelvic pain syndromes
Brian A Parsons, Andrew P Baranowski, Bary Berghmans, et al.
Translational Oncology
|
January 5, 2025
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
Kimberly J Briggs, Kevin M Cottrell, Matthew R Tonini, et al.
The Journal of Biological Chemistry
|
February 10, 2004
In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms
Chao Lin, Kai Lin, Yu-Ping Luong, et al.
European Urology Open Science
|
September 15, 2023
The Benefits and Harms of Pharmacological Treatment for Postradiation Pelvic Pain: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel with Recommendations for Clinical Practice
Valentin Zumstein, Brian A Parsons, Saeed Dabestani, et al.
European Urology Focus
|
August 9, 2022
Myofascial Pelvic Pain: Best Orientation and Clinical Practice. Position of the European Association of Urology Guidelines Panel on Chronic Pelvic Pain
Pedro Abreu-Mendes, Andrew P Baranowski, Bary Berghmans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2025
MTA-Cooperative PRMT5 Inhibitors are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
Xiaochun Zhang, Dana C Borcherding, Minjie Zhang, et al.
European Urology Focus
|
February 2, 2021
The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel
Brian A Parsons, Sanchia Goonewardene, Saeed Dabestani, et al.
Journal of Medicinal Chemistry
|
April 10, 2024
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted Cancers
Kevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, et al.
Journal of Medicinal Chemistry
|
June 30, 2015
Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γ
Philip N Collier, David Messersmith, Arnaud Le Tiran, et al.
Page
of 17